Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoer Jingxing Zhike Granules for postinfectious cough in children (Phase IV cohort)
ChiCTR2400086123Phase 4Not yet recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jun 2024
- Countries
- 1
01
Overview
Phase 4, open-label trial of xiaoer jingxing zhike in postinfectious cough (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Cough resolution rate/time. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
xiaoer jingxing zhike
03
Conditions
postinfectious cough
Beyond the preview
Go deeper on ChiCTR2400086123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086123.